You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unresectable hilar cholangiocarcinoma

Showing 1 - 25 of 3,029
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unresectable Hilar Cholangiocarcinoma Trial in Nanjing (REMS+TAI, SEMS+TAI)

Not yet recruiting
  • Unresectable Hilar Cholangiocarcinoma
  • REMS+TAI
  • SEMS+TAI
  • Nanjing, Jiangsu, China
    Zhongda Hospital,Southeast University
Mar 15, 2021

Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

Not yet recruiting
  • Recurrent Biliary Tract Carcinoma
  • +13 more
  • (no location specified)
Nov 8, 2022

Cholangiocarcinoma, Hilar, Biliary Stricture, Hilar Cholangiocarcinoma Trial in Hangzhou (Endoscopic nasobiliary duct cutting,

Recruiting
  • Cholangiocarcinoma, Hilar
  • +6 more
  • Endoscopic nasobiliary duct cutting
  • Bilateral plastic stent
  • Hangzhou, Zhejiang, China
    Hangzhou First People's Hospital
Oct 24, 2023

Perihilar Cholangiocarcinoma Trial in Padova (Liver transplantation)

Not yet recruiting
  • Perihilar Cholangiocarcinoma
  • Liver transplantation
  • Padova, Italy
    Azienda Ospedale Università di Padova
Nov 5, 2023

EUS-FNA/B Versus ERCP With or Without POCS-TB in Suspected Hilar

Not yet recruiting
  • Klatskin Tumor
  • +3 more
  • The sampling method selected in patients with suspected hilar cholangiocarcinoma
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Aug 14, 2023

Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound

Recruiting
  • Hilar Cholangiocarcinoma
  • +4 more
  • Endoscopic Ultrasound registration
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus University Medical Center
Jan 11, 2023

Hilar Cholangiocarcinoma, Biliary Obstruction Trial in Bangkok (ELRA endoluminal radiofrequency ablation electrode (Taewoong,

Completed
  • Hilar Cholangiocarcinoma
  • Biliary Obstruction
  • ELRA endoluminal radiofrequency ablation electrode (Taewoong, Seoul, Korea)
  • Bangkok, Thailand
    Rajavithi Hospital
Mar 22, 2022

Lymph Node Metastasis Status of Hilar Cholangiocarcinoma

Recruiting
  • Hilar Cholangiocarcinoma
  • No interventions
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 16, 2022

Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant

Not yet recruiting
  • Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Liver Transplant
  • Newark, New Jersey
  • +1 more
Nov 14, 2023

Cholangiocarcinoma Trial in Navi Mumbai (High Dose Radiation, Systemic chemo)

Recruiting
  • Cholangiocarcinoma
  • High Dose Radiation
  • Systemic chemotherapy
  • Navi Mumbai, Maharashtra, India
    Advanced Centre of Treatment Research and Education In Cancer,Ta
Oct 20, 2022

Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)

Recruiting
  • Carcinoma
  • +4 more
  • Guangzhou, Guangdong, China
    Lei Zhang
Jun 21, 2023

Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)

Not yet recruiting
  • Unresectable Intrahepatic Cholangiocarcinoma
  • (no location specified)
Feb 17, 2023

Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Not yet recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +4 more
  • Angiography
  • +8 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Sep 22, 2023

Cholangiocarcinoma Trial in Shanghai (Pemigatinib)

Active, not recruiting
  • Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Oct 3, 2022

Cholangiocarcinoma Non-resectable Trial in China (Hematoporphyrin)

Recruiting
  • Cholangiocarcinoma Non-resectable
  • Chongqing, Chongqing, China
  • +10 more
Aug 7, 2022

Intrahepatic Cholangiocarcinoma Trial in GuangZhou (HAIC Combined with Tislelizumab and Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • HAIC Combined with Tislelizumab and Apatinib
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 4, 2022

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Frankfurt, Hannover, Jena (Delcath Hepatic Delivery System,

Terminated
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • Frankfurt, Germany
  • +2 more
Oct 13, 2022

/or PD-1 Inhibitors for Unresectable Intrahepatic

Completed
  • Intrahepatic Cholangiocarcinoma
  • hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 7, 2022

HER2 Gene Mutation Trial in Shanghai (Injection of IAH0968+Gemcitabine+Cisplatin, Gemcitabine+Cisplatin)

Recruiting
  • HER2 Gene Mutation
  • Injection of IAH0968+Gemcitabine+Cisplatin
  • Gemcitabine+Cisplatin
  • Shanghai, China
    Fudan University Affiliated Zhongshan Hospital
Aug 7, 2023

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (HAIC Combined with Tislelizumab and Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • HAIC Combined with Tislelizumab and Apatinib
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
May 28, 2022

Cholangiocarcinoma Trial in Villejuif (CAPECITABINE-Radiotherapy -Liver Transplantation, RESECTION)

Active, not recruiting
  • Cholangiocarcinoma
  • CAPECITABINE-Radiotherapy -Liver Transplantation
  • RESECTION
  • Villejuif, France
    AP-HP, Paul Brousse Hospital, Centre Hepato-Biliaire
Nov 2, 2021

Cholangitis Trial in Lanzhou, Xi'an, Tianjin (Injection of 37? contrast agent)

Recruiting
  • Cholangitis
  • Injection of 37℃ contrast agent
  • Lanzhou, Gansu, China
  • +2 more
Nov 18, 2021

Hepatocellular Carcinoma, Liver Metastases, Cholangiocarcinoma Trial in United States (STP705)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Hilar Cholangiocarcinoma Trial in Xuzhou (I-125 seeds loaded stent (self-expanded metal stent with I-125 seeds, Micro-Tech,

Enrolling by invitation
  • Hilar Cholangiocarcinoma
  • I-125 seeds loaded stent (self-expanded metal stent with I-125 seeds, Micro-Tech, Nanjing, China)
  • Normal stent (self-expanded metal stent without I-125 seeds, Micro-Tech, Nanjing, China)
  • Xuzhou, Jiangsu, China
    Xuzhou Central Hospital
Jul 12, 2021